WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO is funded by the Walloon Region. Our mission is to support strategic fundamental research through carefully selected projects from universities in the Wallonia-Brussels Federation, with a view to transforming their discoveries into industrial applications in all fields of biotechnology.
Researchers led by Pierre Vanderhaeghen and Jérôme Bonnefont (WELBIO-ULB and VIB-KU Leuven) have unraveled a new mechanism controlling the switch between growth and differentiation of neural stem cells during brain development. Their findings have been published in the journal Neuron.
Recent results just published by WELBIO Investigator Stefan Constantinescu (UCLouvain) and his team in the journal Blood report a novel mechanism by which that a class of mutants in the chaperone calreticulin induce blood cancers denoted as myeloproliferative neoplasms.
A newly discovered bacterium has been named after our research institute. The human gut microbe was discovered during a project led by Patrice Cani (WELBIO & FNRS investigator at UCLouvain), who proposed the scientific name Dysosmobacter welbionis